New Deal in a nutshell

Click play and discover the whys and hows of New Deal in a short animation! From the incidence of IBD in Europe, to the currently available treatments and the solutions proposed by New Deal, in less than three minutes we will walk you through the context of our project and explain you all the basics of our new nanotherapy research

Final Symposium

Highlights from our final symposium online held on 29th September 2021 featuring nanomedicine experts Dr. Fabrice Navarro, Prof. Dr. Gerhard Rogler and Dr. Girija Goyal.

Final video

[DRAFT] The EU-funded New Deal project set out to develop a novel nanotherapy for treating IBD. In this final video, we explain what we’ve achieved in the project and how we’ve worked to revolutionise IBD therapies for the benefit of patients and healthcare systems all over Europe.

IBD&Tea! A debate on the future of IBDs

If you missed our live online session on Twitter, now you can watch it here! We talked to IBD experts coming from different fields that shared their views expertise and concerns on current and future treatment and diagnostic options: Rachel Sawyer (IBD patient and advodate), Dr Azucena Salas (researcher at IDIBAPS) and Prof. Dr. Max Waldner (Professor and clinician at the University Hospital Erlangen)[Sound issues fixed after min 5.54]

IBD&Tea: Building trust in new treatments and understanding clinical trials

IBD&Tea: The gut-brain dialogue: addressing mental health in IBD patients

The science behind New Deal

In this short documentary, you will learn about some of the key scientific concepts needed to understand what we do at New Deal. Join us in this walk around CEA Grenoble and discover from the first- hand experience of our partners how we work to develop a new nanotherapeutic strategy to treat IBD. 

From Bench to bedside

In this second documentary you will discover the steps that we follow to bring our new nanotherapy closer to the clinic. In this visit to IDIBAPS and Hospital Clinic in Barcelona, you will learn more about all the efficacy and safety evaluations that we are working on before our therapy can reach the clinical trials required to treat IBD patients in the future. 


A new issue every three months!


A communication guide for researchers

While scientist efficiently communicate among themselves through technical channels such as specialised journals or conferences, communicating science to a broader audience becomes a difficult task. The inherent uncertainty of scientific findings, the jargon and the required precision that they are used to dealing with as researchers separate them from other audiences.

This guide includes a series of tools to overcome this limitation covering the basics of scientific communication to help you down the stairs of the Ivory Tower. And we will delve into the communication needs of different audiences, particularly in patients with chronic diseases, such as Inflammatory Bowel Diseases.